Diversified Trust’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $795K | Sell |
170,235
-5,504
| -3% | -$25.7K | 0.02% | 444 |
|
|
2025
Q1 | $965K | Hold |
175,739
| – | – | 0.02% | 371 |
|
|
2024
Q4 | $596K | Hold |
175,739
| – | – | 0.01% | 540 |
|
|
2024
Q3 | $501K | Hold |
175,739
| – | – | 0.01% | 584 |
|
|
2024
Q2 | $395K | Sell |
175,739
-2
| -0% | -$4 | 0.01% | 605 |
|
|
2024
Q1 | $388K | Buy |
175,741
+20,091
| +13% | +$44.4K | 0.01% | 580 |
|
|
2023
Q4 | $366K | Sell |
155,650
-19,757
| -11% | -$46.4K | 0.01% | 593 |
|
|
2023
Q3 | $326K | Hold |
175,407
| – | – | 0.01% | 590 |
|
|
2023
Q2 | $460K | Buy |
175,407
+19,757
| +13% | +$51.8K | 0.02% | 492 |
|
|
2023
Q1 | $254K | Hold |
155,650
| – | – | 0.01% | 691 |
|
|
2022
Q4 | $207K | Hold |
155,650
| – | – | 0.01% | 723 |
|
|
2022
Q3 | $243K | Hold |
155,650
| – | – | 0.01% | 621 |
|
|
2022
Q2 | $240K | Hold |
155,650
| – | – | 0.01% | 632 |
|
|
2022
Q1 | $398K | Hold |
155,650
| – | – | 0.01% | 522 |
|
|
2021
Q4 | $456K | Buy |
+155,650
| New | +$456K | 0.02% | 488 |
|